215 related articles for article (PubMed ID: 10408001)
1. [Prevention of coronary heart diseases in clinical practice. Comment on the recommendations of the Second Joint Task Force of European Societies for Prevention of Coronary Disease].
Klein W; Maurer G; Patsch JR; Sandhofer F; Silberbauer K
Wien Med Wochenschr; 1999; 149(5-6):111-8. PubMed ID: 10408001
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)].
de Backer G; Graham I; Poole-Wilson P; Pyörälä K; Shepherd J; Wood D; Zanchetti A
Rev Esp Cardiol; 1995 Dec; 48(12):773-80. PubMed ID: 8685497
[No Abstract] [Full Text] [Related]
3. [Statins in secondary prevention of coronary heart disease].
Sandhofer F
Wien Med Wochenschr; 1999; 149(5-6):125-8. PubMed ID: 10408003
[TBL] [Abstract][Full Text] [Related]
4. [Statins in primary prevention of coronary heart disease].
Paulweber B
Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D; Force T
Cardiologia; 1996 Feb; 41(2):149-82. PubMed ID: 8674094
[No Abstract] [Full Text] [Related]
6. [Hyperlipidemia: decreasing lipid values and effects of statins].
Mathes P
Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
[No Abstract] [Full Text] [Related]
7. [Prevention of coronary disease in clinical practice. Recommendations of the Task-Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D
Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):379-88. PubMed ID: 8561444
[No Abstract] [Full Text] [Related]
8. Serum plant sterols and atherosclerosis: is there a place for statin-ezetimibe combination?
Radermecker RP; Scheen AJ
J Am Coll Cardiol; 2006 Apr; 47(7):1496-7; author reply 1497-8. PubMed ID: 16580546
[No Abstract] [Full Text] [Related]
9. [Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D
Arch Mal Coeur Vaiss; 1995 Oct; 88(10 Suppl):1493-542. PubMed ID: 8815824
[No Abstract] [Full Text] [Related]
10. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
Rydén L; Standl E; Bartnik M; Van den Berghe G; Betteridge J; de Boer MJ; Cosentino F; Jönsson B; Laakso M; Malmberg K; Priori S; Ostergren J; Tuomilehto J; Thrainsdottir I; Vanhorebeek I; Stramba-Badiale M; Lindgren P; Qiao Q; Priori SG; Blanc JJ; Budaj A; Camm J; Dean V; Deckers J; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo J; Zamorano JL; Deckers JW; Bertrand M; Charbonnel B; Erdmann E; Ferrannini E; Flyvbjerg A; Gohlke H; Juanatey JR; Graham I; Monteiro PF; Parhofer K; Pyörälä K; Raz I; Schernthaner G; Volpe M; Wood D; ;
Eur Heart J; 2007 Jan; 28(1):88-136. PubMed ID: 17220161
[No Abstract] [Full Text] [Related]
11. Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
Gotto AM; Whitney E; Stein EA; Shapiro DR; Clearfield M; Weis S; Jou JY; Langendörfer A; Beere PA; Watson DJ; Downs JR; de Cani JS
Eur Heart J; 2000 Oct; 21(19):1627-33. PubMed ID: 10988016
[TBL] [Abstract][Full Text] [Related]
12. [A synthesis of the guidelines of the ESC/EAS/ESH on the prevention of coronary disease and of the guidelines of the Task Force for the Prevention of Coronary Heart Disease. European Society of Cardiology].
Mancia G; Mariani M; Paoletti R
Ital Heart J Suppl; 2000 May; 1(5):690-1. PubMed ID: 10834136
[No Abstract] [Full Text] [Related]
13. [Treatment of lipid disorders for coronary heart disease prevention according to International Atherosclerosis Society recommendations].
Idzior-Waluś B
Przegl Lek; 1999; 56(5):372-6. PubMed ID: 10554575
[TBL] [Abstract][Full Text] [Related]
14. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
[TBL] [Abstract][Full Text] [Related]
15. Primary and secondary prevention of coronary heart disease. Evidence offers multiple strategies.
Lynn MM
Adv Nurse Pract; 2000 Jun; 8(6):36-41; quiz 42-3. PubMed ID: 15658206
[No Abstract] [Full Text] [Related]
16. [Prevention of coronary disease in clinical practice. Guidelines of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
Pyorala K; De Backer G; Graham I; Poole-wilson P; Wood D
G Ital Cardiol; 1996 Feb; 26(2):127-68. PubMed ID: 8666173
[No Abstract] [Full Text] [Related]
17. The case for medical treatment in chronic stable coronary artery disease.
Nash DT
Arch Intern Med; 2005 Dec 12-26; 165(22):2587-9, discussion 2593-4. PubMed ID: 16344414
[No Abstract] [Full Text] [Related]
18. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
De Backer G; Ambrosioni E; Borch-Johnsen K; Brotons C; Cifkova R; Dallongeville J; Ebrahim S; Faergeman O; Graham I; Mancia G; Cats VM; Orth-Gomér K; Perk J; Pyörälä K; Rodicio JL; Sans S; Sansoy V; Sechtem U; Silber S; Thomsen T; Wood D;
Eur J Cardiovasc Prev Rehabil; 2003 Aug; 10(4):S1-S10. PubMed ID: 14555889
[TBL] [Abstract][Full Text] [Related]
19. Genetic determinants of response to statins.
Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
[TBL] [Abstract][Full Text] [Related]
20. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
Motz W
MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
[No Abstract] [Full Text] [Related]
[Next] [New Search]
